Inventiva Financial Statements From 2010 to 2026
| IVEVF Stock | USD 4.44 0.00 0.00% |
Check Inventiva financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inventiva's main balance sheet or income statement drivers, such as , as well as many indicators such as . Inventiva financial statements analysis is a perfect complement when working with Inventiva Valuation or Volatility modules.
Inventiva |
Inventiva SA Company Operating Margin Analysis
Inventiva's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Inventiva Operating Margin | (6.37) % |
Most of Inventiva's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inventiva SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Inventiva SA has an Operating Margin of -6.3673%. This is 81.85% lower than that of the Healthcare sector and 94.32% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 15.56% higher than that of the company.
Inventiva SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inventiva's current stock value. Our valuation model uses many indicators to compare Inventiva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inventiva competition to find correlations between indicators driving Inventiva's intrinsic value. More Info.Inventiva SA is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inventiva's earnings, one of the primary drivers of an investment's value.About Inventiva Financial Statements
Inventiva stakeholders use historical fundamental indicators, such as Inventiva's revenue or net income, to determine how well the company is positioned to perform in the future. Although Inventiva investors may analyze each financial statement separately, they are all interrelated. For example, changes in Inventiva's assets and liabilities are reflected in the revenues and expenses on Inventiva's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Inventiva SA. Please read more on our technical analysis and fundamental analysis pages.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inventiva Pink Sheet
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out the analysis of Inventiva Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.